Champions Oncology, Inc.

Champions Oncology, Inc. is a pioneering company in the field of personalised medicine, dedicated to advancing cancer treatment through innovative technology and research. Established with the vision of improving patient outcomes, Champions Oncology focuses on developing advanced solutions that enable oncologists to tailor therapies based on individual patient profiles.

The company’s core offerings include the Champions TumourGraft® platform, which allows for the creation of patient-derived xenograft models. These models are instrumental in predicting how patients will respond to various treatments, thereby facilitating more effective and targeted therapeutic strategies.

In addition to its cutting-edge research, Champions Oncology collaborates with leading academic institutions and pharmaceutical companies to enhance drug development processes. This collaboration ensures that the latest scientific advancements are integrated into clinical practice, ultimately benefiting patients worldwide.

Champions Oncology is committed to fostering a culture of innovation and excellence. The company invests significantly in research and development, striving to stay at the forefront of oncology advancements. With a team of experienced professionals, Champions Oncology aims to transform the landscape of cancer treatment.

• Core Activities: Development of personalised cancer treatment solutions.
• Vision: To improve patient outcomes through innovative oncology research.
• Collaboration: Partnering with academic and pharmaceutical leaders.

Headquartered in the UK, Champions Oncology is strategically positioned to influence global cancer care. The company’s dedication to scientific excellence and patient-centric approaches makes it a leader in the oncology field, paving the way for future breakthroughs in cancer treatment.